COVID-19, asthma, and biological therapies: what we need to know

COVID-19, asthma, and biological therapies: what we need to know

Managing patients with severe asthma during the coronavirus pandemic and COVID-19 is a challenge. Authorities and physicians are still learning how COVID-19 affects people with underlying diseases, and severe asthma is not an exception. Unless relevant data emerge that change our understanding of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Morais Almeida, Mario, Aguiar, Rita, Martin, Bryan, Ansotegui, Ignacio J., Ebisawa, Motohiro, Arruda, L. Karla, Caminati, Marco, Canonica, Giorgio Walter, Carr, Tara, Chupp, Geoffrey, Corren, Jonathan, Dávila, Ignacio, Park, Hae-Sim, Hanania, Nicola A., Rosenwasser, Lanny, Sánchez Borges, Mario, Virchow, J. Christian, Yáñez, Anahí, Bernstein, Jonathan A., Caraballo, Luis R., Chang, Yoon-Seok, Chikhladze, Manana, Fiocchi, Alessandro, González Díaz, Sandra Nora, Tanno, Luciana Kase, Levin, Michael, Ortega Martell, José Antonio, Passalacqua, Giovanni, Peden, David B., Rouadi, Philip W., Sublett, James L., Wong, Gary W.K., Bleecker, Eugene R.
Formato: Artículo
Lenguaje:English
Publicado: 2020
Materias:
RC Medicina Interna, Psiquiatría, Neurología
Acceso en línea:http://eprints.uanl.mx/20097/1/1-s2.0-S1939455120300296-main.pdf

Ejemplares similares